arrow
C

Clare M. Tempany

radiology
H指数:71
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Systematic effects of patient factors and scanner/protocol factors on a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancer

患者因素和扫描仪/协议因素对前列腺癌Restriction Spectrum Imaging (RSI)定量MRI生物标志物的系统性影响

2026-04-160
OAAI
Assessing Quality and Adherence to PI-RADSv2.1 Minimum Technical Standards of Prostate MRI in NRG-GU005

评估前列腺MRI的质量和符合PI-RADSv2.1最低技术标准的情况:NRG-GU005研究

2025-10-080
OAAI
SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis

SPARC:标准化前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描分析与报告共识:一项德尔菲分析

2025-09-130
PREAI
Feasibility of MRI-Guided Transperineal Implantation of Microdevices for Drug Delivery and Response Assessment in Prostate Cancer
2025-04-011
PRE
Advanced Restriction Imaging and Reconstruction Technology for Prostate Magnetic Resonance Imaging (ART-Pro): A Study Protocol for a Multicenter, Multinational Trial Evaluating Biparametric Magnetic Resonance Imaging and Advanced, Quantitative Diffusion Magnetic Resonance Imaging for the Detection of Prostate Cancer

前列腺磁共振成像的高级限制性成像和重建技术 (ART-Pro): 一项评估双参数磁共振成像和高级定量扩散磁共振成像检测前列腺癌的多中心,多国试验的研究方案

2025-01-010
OAAI
PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer
2024-09-018
OA
The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus Recommendations
2024-05-017
OA
The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG-ACRIN Cancer Research Group (EA) trials
CANCER
IF5.1
2023-10-053
OAAI
Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical Trials
2023-07-063
OA
Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting
2023-04-0121
OA